Cellular Trafficking of Nanotechnology‐Mediated mRNA Delivery
P Huang, H Deng, C Wang, Y Zhou… - Advanced …, 2024 - Wiley Online Library
Messenger RNA (mRNA)‐based therapy has emerged as a powerful, safe, and rapidly
scalable therapeutic approach that involves technologies for both mRNA itself and the …
scalable therapeutic approach that involves technologies for both mRNA itself and the …
Nanomaterial-based regulation of redox metabolism for enhancing cancer therapy
X Jia, Y Wang, Y Qiao, X Jiang, J Li - Chemical Society Reviews, 2024 - pubs.rsc.org
Altered redox metabolism is one of the hallmarks of tumor cells, which not only contributes to
tumor proliferation, metastasis, and immune evasion, but also has great relevance to …
tumor proliferation, metastasis, and immune evasion, but also has great relevance to …
Targeted delivery of hybrid nanovesicles for enhanced brain penetration to achieve synergistic therapy of glioma
R Wang, X Wang, H Zhao, N Li, J Li, H Zhang… - Journal of Controlled …, 2024 - Elsevier
Blood-brain barrier (BBB) obstructing brain drug delivery severely hampers the therapeutic
efficacy towards glioma. An efficient brain delivery strategy is of paramount importance for …
efficacy towards glioma. An efficient brain delivery strategy is of paramount importance for …
Genetically engineered biomimetic nanoparticles for targeted delivery of mRNA to treat rheumatoid arthritis
J Chen, J Tan, J Li, W Cheng, L Ke, A Wang… - Small …, 2023 - Wiley Online Library
In addition to inhibiting persistent inflammation, phosphatase and tensin homolog deleted
from chromosome 10 (PTEN) is known as an important therapeutic target for alleviating …
from chromosome 10 (PTEN) is known as an important therapeutic target for alleviating …
Small Scale, Big Impact: Nanotechnology-Enhanced Drug Delivery for Brain Diseases
Central nervous system (CNS) diseases, ranging from brain cancers to neurodegenerative
disorders like dementia and acute conditions such as strokes, have been heavily burdening …
disorders like dementia and acute conditions such as strokes, have been heavily burdening …
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Y Shi, M Shi, Y Wang, J You - Signal Transduction and Targeted …, 2024 - nature.com
In the last decade, messenger ribonucleic acid (mRNA)-based drugs have gained great
interest in both immunotherapy and non-immunogenic applications. This surge in interest …
interest in both immunotherapy and non-immunogenic applications. This surge in interest …
Stimuli-responsive polymeric nanocarriers accelerate on-demand drug release to combat glioblastoma
Glioblastoma multiforme (GBM) is a highly malignant brain tumor with a poor prognosis and
limited treatment options. Drug delivery by stimuli-responsive nanocarriers holds great …
limited treatment options. Drug delivery by stimuli-responsive nanocarriers holds great …
Recent advances in biomimetic strategies for the immunotherapy of glioblastoma
Immunotherapy is regarded as one of the most promising approaches for treating tumors,
with a multitude of immunotherapeutic thoughts currently under consideration for the lethal …
with a multitude of immunotherapeutic thoughts currently under consideration for the lethal …
Revolutionizing neurocare: biomimetic nanodelivery via cell membranes
J Liao, L Gong, Q Xu, J Wang, Y Yang… - Advanced …, 2024 - Wiley Online Library
Brain disorders represent a significant challenge in medical science due to the formidable
blood–brain barrier (BBB), which severely limits the penetration of conventional …
blood–brain barrier (BBB), which severely limits the penetration of conventional …
[HTML][HTML] Recent Advancements in mRNA Vaccines: From Target Selection to Delivery Systems
Z Wu, W Sun, H Qi - Vaccines, 2024 - mdpi.com
mRNA vaccines are leading a medical revolution. mRNA technologies utilize the host's own
cells as bio-factories to produce proteins that serve as antigens. This revolutionary approach …
cells as bio-factories to produce proteins that serve as antigens. This revolutionary approach …